Etomidate Injection
Product Images NDC 51662-1485

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Etomidate (NDC 51662-1485). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pplied (How Supplied)

This is a description of a medication with a concentration of 2 mg/mL and container size of 10 mL. It has an NDC number of 0143-9506-10 and comes in a carton of 10 vials. Additionally, there is another package size available with a concentration of 2 mg/mL, container size of 20 mL, and an NDC number of 0143-9507-10, also coming in a carton of 10 vials.*

FDA Label Image

Serialized Labeling (Seerialized Vial Labeling)

This text seems to be a product label for Etomidate injection with information on the manufacturer's package insert, distribution, and National Drug Code (NDC). It provides instructions for the use of the product in intravenous administration.*

FDA Label Image

Structure (Structure)

FDA Label Image

Vial Label (Vial Label)

This is a product description for a medication called Etomidate Injection, USP. The medication is stored in a 10mL single dose vial and is for intravenous use only. The vial contains etomidate 2 mg and propylene glycol 35% viv per mL. The medication is sterile and nonpyrogenic. The usual dosage should be obtained from the package insert. The medication should be stored at 20° to 25°C (68° to 77°F). The product is manufactured by HIOA Farmaceutica Portugall SA and distributed by G Westward of Eatontown, NJ.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.